Azidus Laboratories Ghana
↗Tema, Ghana
Azidus Laboratories Ghana is a specialized Clinical Research Organization (CRO) and the first dedicated Bioavailability and Bioequivalence (BA/BE) center in West Africa. It serves as a key international hub for Azidus Laboratories (headquartered in Chennai, India), providing end-to-end clinical research solutions to the pharmaceutical and biotechnology industries.
The company offers a comprehensive suite of services, including BA/BE studies, clinical trial management, bioanalytical services, clinical data management, pharmacovigilance, and regulatory submission support. By adhering to international standards such as GCP and GLP, Azidus Ghana facilitates the development and accessibility of quality generic medicines in the region while supporting global drug regulatory requirements.
CLASSIFICATION
SIZE & FINANCIALS
Employees:51-200
Founded:2015
Ownership:subsidiary
Status:operating
PIPELINE
Modalities:Small molecule, Liposomal products
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Azidus Laboratories (India)
Key Partnerships:Global pharmaceutical and biotechnology companies requiring BA/BE and clinical trial services.
COMPETITION
Position:Niche Player
Competitors:IQVIA, ICON plc, Parexel, Syneos Health
LEADERSHIP
Key Executives:
Not publicly disclosed for Ghana branch
LINKS
Website:azidusghana.com
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Azidus Laboratories Ghana and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Azidus Laboratories Ghana. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.